FIRST ON THE DAILY SIGNAL—A coalition of 60 lawmakers filed an amicus brief supporting a lawsuit to limit the abortion pill after the Trump administration requested a pause to the case, The Daily Signal can first report. On Friday, 58 Republican representatives and senators, led by Senator Bill Cassidy of Louisiana and Rep. Chris Smith of New Jersey, filed the amicus brief in support of Louisiana’s effort to restore the in-person dispensing requirement on the abortion pill. amDownload Louisiana Attorney General Liz Murrill filed a lawsuit in 2025 challenging a Biden-era rule allowing abortion drugs to be dispensed to women through the mail without seeing a doctor first. A hearing for State of Louisiana v. Food and Drug Administration is scheduled for Feb. 24. Ahead of the hearing, President Donald Trump’s Department of Justice asked a federal court to pause Louisiana’s case against the Food and Drug Administration while the agency conducts a safety review into the abortion drug mifepristone. “I thank Attorney General Murrill for defending women and babies in Louisiana and across the country. Chemical abortion drugs kill innocent children and put mothers’ lives at risk,” said Cassidy, who chairs the Senate Health, Education, Labor, and Pensions Committee. “Safeguards protecting against coercion, such as the in-person dispensing requirement, must be reinstated immediately.”  ‘Why Is It Taking So Long’? Senate Health Chair Urges Immediate FDA Action on Abortion PillThe Food and Drug Administration should “immediately” restore in-person dispensing requirements for the abortion pill, Sen. Bill Cassidy, R-La., told @TheElizMitchell. The senator… pic.twitter.com/F54LzanmJi— The Daily Signal (@DailySignal) January 14, 2026 Louisiana filed the lawsuit alongside resident Rosalie Markezich, who says her boyfriend coerced her into taking abortion pills, which he ordered from a doctor in California. While Louisiana law prohibits abortions in almost all cases, the lack of an in-person dispensing requirement on the drugs allowed him to obtain the drugs out of state through the mail. The GOP lawmakers argue that Biden violated federal law by removing the in-person dispensing requirement, and that these protections should be reinstated. When Congress passed the Comstock Act, it declared that abortion drugs are “nonmailable matter” by the United States Postal Service and private carriers, but the Biden administration illegally allowed abortion pills to be shipped across the country, the brief states. “This action contravenes federal laws passed by the elected representatives of the American people,” according to the brief. “It also contravenes state laws prohibiting abortion, such as Louisiana’s, even though ‘the authority to regulate abortion’ belongs to ‘the people and their elected representatives,’ not unelected bureaucrats.” The Biden FDA also did not properly consider the safety risk of the abortion pill when removing the in-person dispensing requirement, according to the lawmakers. A study from the Ethics and Public Policy Center found that 11% of women experience adverse health effects, such as sepsis, infection, hemorrhaging, within 45 days following a mifepristone abortion. EXCLUSIVE??: @DrMakaryFDA responded to a report saying he is delaying the review of the abortion pill.The FDA is currently in the “data acquisition phase” of the review," he told @DailySignal.“We do an ongoing review, but we’re also engaging in a robust study that can serve… pic.twitter.com/bhkTwXqvby— Elizabeth Troutman Mitchell (@TheElizMitchell) December 9, 2025 “The Biden FDA did not have a sufficient evidentiary basis to conclude that eliminating the in-person dispensing requirement was safe,” the brief says. “And because no in-person visit is required now, women cannot be meaningfully screened for serious contraindications for the use of this drug, such as ectopic pregnancy.” “It also increases the likelihood that some women are being coerced into taking these drugs against their will, as the heartbreaking story of Plaintiff Rosalie Markezich illustrates,” the brief continues. The amicus brief supports Murrill’s motion for preliminary relief and asks for a preliminary injunction ordering FDA to suspend or withdraw the 2023 Risk Evaluation and Mitigation Strategy while the case proceeds.   Mifepristone has become the most common abortion method, accounting for about 63% of all abortions, according to the Guttmacher Institute, Planned Parenthood’s research arm. However, this is likely an undercount, according to the pro-life Charlotte Lozier Institute, because this count does not include abortions outside the formal health care system or under shield laws. Shield laws allow abortionists to mail abortion drugs to women, including those in states that prohibit most abortions or impose gestational limits. Murrill previously told The Daily Signal she is hopeful the judge will reject the Trump administration’s request to pause her lawsuit seeking to reinstate regulations of the abortion pill. “I am certainly hopeful that he will not accept the Department of Justice’s position, because they haven’t given any concrete reason to believe they are actually moving forward,” she said. The entry of abortion pills into Louisiana is dangerous, illegal, unethical. We’ve seen the harms that have come to women from the kind of unrestricted flooding of these pills into our states, and we’ve had numerous cases show up in emergency rooms. Louisiana will always protect… https://t.co/G3gKHb6Obb— Attorney General Liz Murrill (@AGLizMurrill) January 30, 2026 At the time, a spokesperson for the Justice Department told The Daily Signal in a statement that the agency “remains committed to advancing President Trump’s pro-life agenda, including through dismissing criminal prosecutions and civil lawsuits against peaceful pro-life advocates targeted by the previous administration, and using the FACE Act to protect pro-life pregnancy centers.” “In this filing, the Department of Justice simply requested more time from the court for the FDA to complete its review of mifepristone REMS,” the spokesperson added. A Risk Evaluation and Mitigation Strategy, or REMS, is a protocol for the FDA to ensure safe usage of higher-risk drugs. “As the Supreme Court recognized in a unanimous ruling less than two years ago,” the spokesperson continued, “it is the role of the FDA—not the federal courts—to evaluate drug safety data and impose appropriate precautions.” The post EXCLUSIVE: 60 Lawmakers Support Lawsuit to Limit Abortion Pill After Trump Requested Pause appeared first on The Daily Signal.

AOC’s time at the Munich conference was another reminder that no matter how much she is billed as a rising star, she is still callow and unserious.

'Clean Up, Aisle Sandy!' AOC Faceplants BIG TIME on World Stage, Sprints to NYT for Rescue and ROFL

‘Do Not Wonder Why We Go BERSERK’: More on the Transgender Hockey Shooter’s Background

James Woods Just Needs One TEENY-TINY Word to Trigger the Ever-Loving EFF Out of Sarah (Tim) McBride

Navarro Signals Trump May Force Big Tech to Pay Full AI Energy Costs

Trump Withholds Endorsement As Texas GOP Senate Primary Early Voting Begins

Silicon-Carbon batteries have revolutionized phones with their incredibly high charge capabilities, but Apple and Google may be avoiding them for a good reason.

A Russian court has sentenced a U.S. citizen to four years in jail for trying to take the stocks of Kalashnikov assault rifles out of a Moscow airport, the RIA state news agency reported on Tuesday.

Goldman Sachs is preparing to eliminate diversity, equity and inclusion criteria from the process it uses to select new board members, The Wall Street Journal reports.